New Faces Join Efforts to Address Health Disparities

Five amazing, dynamic, and extremely well-intentioned professionals have committed themselves to promoting health equity by joining the PlusInc Board of Directors. By lending their expertise and experience to our leadership, PlusInc has taken a giant step forward in our efforts to address health disparities.

In late 2022, PlusInc seated a trio of fabulous women — Kassy Perry, Laura Friedman, Meg Cooksey — from three very different lines of work. Kassy Perry is a force all her own. A shrewd strategic thinker with uncommon creativity, Kassy is also a smart tactician. She presently serves as the President & CEO of Perry Communications Group, , which she founded in 1996. Laura Friedman is currently a Senior Vice President, Communications and People Strategy Lead for Markets Technology at Citigroup. Prior to joining Citi, she previously served as the Associate Director of Communications at Workforce Opportunity Services (WOS), as well as the Communications and Programs Manager at Hearing Health Foundation (HHF). Mary M. “Meg” Cooksey, RN-BC, currently serves as Nurse Manager for the Division of Infectious Diseases at MedStar Georgetown University. Meg is Board-Certified in Ambulatory Care Nursing and has a special interest in ensuring equity in access to vaccines for underserved populations.

In early 2023, PlusInc seated a dynamic duo: Glen Pietrandoni and Vanessa Lathan. Glen Pietrandoni, R.Ph., AAHIVP is chief advocacy officer at Avita Care Solutions, passionate healthcare advocate, and internationally respected HIV and LGBTQ+ activist. Glen is deeply engaged in Avita's mission to advocate for health equity and the 340B Drug Pricing program. Vanessa Lathan, MPH, BSW is an HBCU-educated, unapologetic Black and communities of color-focused change agent driven to dismantle oppressive and systemic racism policies within sexual and reproductive health. Vanessa is a Senior Program Manager for the Southern HIV Impact Fund program at AIDS United.

These new faces join long-time board members, Andrew Richter and Michelle Anderson, as well as 2021-seated board members, Michael Pickering, and Jonathan J. Pena, MSW, LCSW-A. Check out our phenomenal leadership team here!

Previous
Previous

Diversity in Clinical Trials Still Lags

Next
Next

Health Disparities Portfolio Expanded to Include More Chronic Health Conditions